Clinical practice. Aspirin for primary prevention of coronary events
about
sameAs
Primary prevention of coronary heart disease in the elderlyAspirin: still learning about the wonder drugGiving aspirin and ibuprofen after myocardial infarctionCardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicityRole of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug usersLumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjectsIs there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Analysis of aspirin-associated risks in healthy individualsRole of clopidogrel in unstable angina and non-ST-segment elevation myocardial infarction: from literature and guidelines to practiceFrequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirinManagement of cardiovascular complications in systemic lupus erythematosus.Shaping the platelet response to vascular injury.Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice.The metabolic syndrome: an emerging risk state for cardiovascular disease.Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies.Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.Antiplatelet therapy: current strategies and future trends.The effect of aspirin on kidney allograft outcomes; a short review to current studies.A Comparative Study to Determine the Effect of Intravenous Magnesium on Postoperative Bleeding after on Pump CABG in Patients Receiving Pre-Operative Aspirin.Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.Premature coronary heart disease in SLE: can we prevent progression?One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.Awareness of physicians in Jordan about the treatment of high blood pressure according to the seventh report of the Joint National Committee (JNC VII)
P2860
Q28165739-25ECDE95-9634-4758-9A0A-260187AE040CQ28165768-18EB6084-7C7D-423E-B8B0-35A1ECC957A4Q28166360-7E5E1581-D120-4338-9AFA-DF486A5A62FDQ28166985-31954B73-AE8C-4973-95F8-B9FC52AAA4CEQ28182449-A3A4CECB-3EAA-49D2-8512-FE5B39A408B7Q28192026-6371DEFB-35EE-4982-AF7E-8E439A730B0DQ28196511-55CCAC67-D068-4A1B-9798-6FEFBA7D5C16Q28211608-4EB46F1B-FA63-41AE-844B-A2BAEA260D50Q28211998-6B48AFA5-D9EC-436B-A8B4-CB917C75C517Q28212922-8EAAC99C-F33E-4788-B49A-0FAD65D41EC7Q33730536-ED19361C-02C5-4605-BE62-4CDF221E7B40Q34245348-DBDCA534-D7AF-4B24-9EB8-C1979AD2C640Q35144122-A6F87A60-F0F4-4554-A477-7D0E245AA39BQ35824621-1F33BBA2-C293-4431-8FA9-5D5649CC7674Q37327687-171E9A99-985C-4860-9E9A-C8914F2AE5ABQ38028441-67107186-B5DC-465E-A581-B8EA187248F2Q38589520-5E436B3F-A10E-4438-BAAA-D90D535F2A76Q40180037-A5DA0A16-9283-4CED-B762-B63C63B558CDQ40329892-2AD8A4FB-7CC4-4DAA-BB0D-1FD758CFD7BDQ42361916-CA6AF132-7BC1-43DE-8671-EAA63636C245Q42736301-ED8DDFB3-C734-4758-B6B2-993713F57AF0Q42873633-24D50445-4EF4-48CC-935B-A38D1F47536EQ43216541-4F71692F-3F49-46E8-B32A-78B248893543Q43900414-1EF4EF4F-519A-422A-8C07-180891917C61Q55373359-37E512BF-D8D5-4E0D-9EE8-42256A1E690DQ57312195-547F58AB-0359-464C-A157-B42753BEAFFA
P2860
Clinical practice. Aspirin for primary prevention of coronary events
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical practice. Aspirin for primary prevention of coronary events
@ast
Clinical practice. Aspirin for primary prevention of coronary events
@en
Clinical practice. Aspirin for primary prevention of coronary events
@nl
type
label
Clinical practice. Aspirin for primary prevention of coronary events
@ast
Clinical practice. Aspirin for primary prevention of coronary events
@en
Clinical practice. Aspirin for primary prevention of coronary events
@nl
prefLabel
Clinical practice. Aspirin for primary prevention of coronary events
@ast
Clinical practice. Aspirin for primary prevention of coronary events
@en
Clinical practice. Aspirin for primary prevention of coronary events
@nl
P356
P1476
Clinical practice. Aspirin for primary prevention of coronary events
@en
P2093
Michael S Lauer
P304
P356
10.1056/NEJMCP012672
P407
P577
2002-05-09T00:00:00Z